AIM: To explore the effects of dendritic cells (DC) and cytokine-induced killer cells (CIK) carrying melanoma-associated antigen gene A3 (MAGE-A3) on endometrial cancer tumor stem cells and malignant progression. METHODS: Human peripheral blood was collected to separate mono-nuclear cells, and DC and CIK cells were induced by cytokines, respectively. DCs were incubated with MAGE-A3 and then co-cultured with CIK, and the phenotypes of DC-CIK and MAGE-A3-DC-CIK were detected by flow cytometry; The CD133

Objective:To explore the feasibility and clinical effects of using superficial temporal artery lobulated perforator flaps in repairing skin and soft tissue defects after tumor resection in the temporal region.Methods:A retrospective observational study method was used. From March 2017 to October 2022, ten patients with temporal skin tumors were admitted to the Affiliated Hospital of Zunyi Medical University, including six women and four men, with age ranging from 42 to 87 years. Among them, three patients had squamous cell carcinoma and seven patients had basal cell carcinoma, with disease duration ranging from 6 months to 5 years. All temporal tumors underwent expanded resection, leaving wound areas of 5.4 cm×4.2 cm to 7.0 cm×4.0 cm after tumor resection. Superficial temporal artery frontal branch flaps with areas of 5.5 cm×1.2 cm to 7.0 cm×1.5 cm, superficial temporal artery descending branch flaps with areas of 4.2 cm×3.5 cm to 5.0 cm×4.0 cm, and superficial temporal artery parietal branch flaps with areas of 4.2 cm×1.0 cm to 5.0 cm×1.0 cm were designed to repair the wounds and reconstruct the hairline. The donor areas of the flaps were closed and sutured directly. The survival of the flaps was observed on 3 to 5 days after surgery, and the healing of wounds on the donor and recipient sites was observed when the stitches were removed on 5 to 7 days after surgery. During follow-up after surgery, the appearance of the temporal area, scar hyperplasia, hairline reconstruction, and tumor recurrence were observed in the temporal region on the affected side.Results:All the flaps survived well on 3 to 5 days after surgery, and all the donor and recipient site wounds healed well on 5 to 7 days after surgery. During follow-up of 3 to 6 months after surgery, the surgical incisions were concealed; the flaps were not swollen, with a consistent color to the surrounding skin; there were no obvious hypertrophic scars; the reconstructed hairline on the affected side was not significantly different from that of the healthy side; there was no tumor recurrence in the local area.Conclusions:For large areas of skin and soft tissue defects in the temporal region, the use of superficial temporal artery lobulated perforator flaps can repair the wounds in different regions and suture the donor sites in the primary stage simultaneously. The surgical operation is simple, and the facial appearance conforms to the aesthetic requirement after surgery with no tumor recurrence in the local area but a good repair effect. This method is particularly suitable for repairing large areas of skin and soft tissue defects in the temporal region in elderly patients.

Objective:To manufacture one kind of biphasic calcium phosphate (BCP) ceramic by hydroxyapatite (HA) and β-tricalciumphosphate (β-TCP), and to further investigate its compatibility and its efficacy of ectopic bone formation.Methods:BCP was prepared with the ratio of HA and β-TCP at 6/4 using precipitation and H 2O 2 foaming method and then sintered at 1 100 ℃ for 3 hours. The chemical composition of BCP was investigated by X-ray diffraction(XRD). BMSCs were isolated from the bone marrow of Sprague-Dawley (SD) rat and seeded on BCP. The adhesion and morphology of BMSCs on BCP was observed under scanning electron microscope(SEM) and special staining. Cell proliferation was quantified by cell counting kit-8(CCK8) assay. Alkaline phosphatase(ALP)activity of BMSCs was measured by ALP assay kit. For further confirmation, the intramuscularly ectopic implantation models of Beagle were used, general observation, histological, and histomorphometric analyses were conducted at 4, 8, 12 weeks after implantation. Results:BCPs were successfully manufactured. XRD analysis showed the specific diffraction peaks of HA and β-TCP. SEM showed that the surface of the BCP ceramics was widely distributed with macropores and connections, and the pore walls were rough, and the micropores were evenly distributed in the macropores. Phalloidin and DAPI staining showed that the BMSCs extended and adhered to the surface of the material, and the shape gradually changed from irregularity to uniform long spindle. CCK8 method showed that although the cell viability decreased on the first day after coculture, on the third, fourth, fifth and seventh days, the cell viability gradually increased. The assay of alkaline phosphatase activity indicated that BMSCs cultured on the BCP could secrete more alkaline phosphatase on day 1 and 7 compared with the control group. BCP implanted in the muscle could generate osteoid/bone tissue at 8 weeks and 12 weeks, the number of osteoid/bone filled pores were 0.77±0.11, the percentage of osteoid/bone tissue inside the pores were 0.71±0.14.Conclusions:The BCP had a good biocompatibility and favorable efficacy of ectopic osteoinduction.

Objective:To manufacture one kind of biphasic calcium phosphate (BCP) ceramic by hydroxyapatite (HA) and β-tricalciumphosphate (β-TCP), and to further investigate its compatibility and its efficacy of ectopic bone formation.Methods:BCP was prepared with the ratio of HA and β-TCP at 6/4 using precipitation and H 2O 2 foaming method and then sintered at 1 100 ℃ for 3 hours. The chemical composition of BCP was investigated by X-ray diffraction(XRD). BMSCs were isolated from the bone marrow of Sprague-Dawley (SD) rat and seeded on BCP. The adhesion and morphology of BMSCs on BCP was observed under scanning electron microscope(SEM) and special staining. Cell proliferation was quantified by cell counting kit-8(CCK8) assay. Alkaline phosphatase(ALP)activity of BMSCs was measured by ALP assay kit. For further confirmation, the intramuscularly ectopic implantation models of Beagle were used, general observation, histological, and histomorphometric analyses were conducted at 4, 8, 12 weeks after implantation. Results:BCPs were successfully manufactured. XRD analysis showed the specific diffraction peaks of HA and β-TCP. SEM showed that the surface of the BCP ceramics was widely distributed with macropores and connections, and the pore walls were rough, and the micropores were evenly distributed in the macropores. Phalloidin and DAPI staining showed that the BMSCs extended and adhered to the surface of the material, and the shape gradually changed from irregularity to uniform long spindle. CCK8 method showed that although the cell viability decreased on the first day after coculture, on the third, fourth, fifth and seventh days, the cell viability gradually increased. The assay of alkaline phosphatase activity indicated that BMSCs cultured on the BCP could secrete more alkaline phosphatase on day 1 and 7 compared with the control group. BCP implanted in the muscle could generate osteoid/bone tissue at 8 weeks and 12 weeks, the number of osteoid/bone filled pores were 0.77±0.11, the percentage of osteoid/bone tissue inside the pores were 0.71±0.14.Conclusions:The BCP had a good biocompatibility and favorable efficacy of ectopic osteoinduction.

Objective:To manufacture one kind of biphasic calcium phosphate (BCP) ceramic by hydroxyapatite (HA) and β-tricalciumphosphate (β-TCP), and to further investigate its compatibility and its efficacy of ectopic bone formation.Methods:BCP was prepared with the ratio of HA and β-TCP at 6/4 using precipitation and H 2O 2 foaming method and then sintered at 1 100 ℃ for 3 hours. The chemical composition of BCP was investigated by X-ray diffraction(XRD). BMSCs were isolated from the bone marrow of Sprague-Dawley (SD) rat and seeded on BCP. The adhesion and morphology of BMSCs on BCP was observed under scanning electron microscope(SEM) and special staining. Cell proliferation was quantified by cell counting kit-8(CCK8) assay. Alkaline phosphatase(ALP)activity of BMSCs was measured by ALP assay kit. For further confirmation, the intramuscularly ectopic implantation models of Beagle were used, general observation, histological, and histomorphometric analyses were conducted at 4, 8, 12 weeks after implantation. Results:BCPs were successfully manufactured. XRD analysis showed the specific diffraction peaks of HA and β-TCP. SEM showed that the surface of the BCP ceramics was widely distributed with macropores and connections, and the pore walls were rough, and the micropores were evenly distributed in the macropores. Phalloidin and DAPI staining showed that the BMSCs extended and adhered to the surface of the material, and the shape gradually changed from irregularity to uniform long spindle. CCK8 method showed that although the cell viability decreased on the first day after coculture, on the third, fourth, fifth and seventh days, the cell viability gradually increased. The assay of alkaline phosphatase activity indicated that BMSCs cultured on the BCP could secrete more alkaline phosphatase on day 1 and 7 compared with the control group. BCP implanted in the muscle could generate osteoid/bone tissue at 8 weeks and 12 weeks, the number of osteoid/bone filled pores were 0.77±0.11, the percentage of osteoid/bone tissue inside the pores were 0.71±0.14.Conclusions:The BCP had a good biocompatibility and favorable efficacy of ectopic osteoinduction.

Objective:To manufacture one kind of biphasic calcium phosphate (BCP) ceramic by hydroxyapatite (HA) and β-tricalciumphosphate (β-TCP), and to further investigate its compatibility and its efficacy of ectopic bone formation.Methods:BCP was prepared with the ratio of HA and β-TCP at 6/4 using precipitation and H 2O 2 foaming method and then sintered at 1 100 ℃ for 3 hours. The chemical composition of BCP was investigated by X-ray diffraction(XRD). BMSCs were isolated from the bone marrow of Sprague-Dawley (SD) rat and seeded on BCP. The adhesion and morphology of BMSCs on BCP was observed under scanning electron microscope(SEM) and special staining. Cell proliferation was quantified by cell counting kit-8(CCK8) assay. Alkaline phosphatase(ALP)activity of BMSCs was measured by ALP assay kit. For further confirmation, the intramuscularly ectopic implantation models of Beagle were used, general observation, histological, and histomorphometric analyses were conducted at 4, 8, 12 weeks after implantation. Results:BCPs were successfully manufactured. XRD analysis showed the specific diffraction peaks of HA and β-TCP. SEM showed that the surface of the BCP ceramics was widely distributed with macropores and connections, and the pore walls were rough, and the micropores were evenly distributed in the macropores. Phalloidin and DAPI staining showed that the BMSCs extended and adhered to the surface of the material, and the shape gradually changed from irregularity to uniform long spindle. CCK8 method showed that although the cell viability decreased on the first day after coculture, on the third, fourth, fifth and seventh days, the cell viability gradually increased. The assay of alkaline phosphatase activity indicated that BMSCs cultured on the BCP could secrete more alkaline phosphatase on day 1 and 7 compared with the control group. BCP implanted in the muscle could generate osteoid/bone tissue at 8 weeks and 12 weeks, the number of osteoid/bone filled pores were 0.77±0.11, the percentage of osteoid/bone tissue inside the pores were 0.71±0.14.Conclusions:The BCP had a good biocompatibility and favorable efficacy of ectopic osteoinduction.

Objective:To systematically understand the global research progress in the construction and validation of lung cancer risk prediction models.Methods:"lung neoplasms" , "lung cancer" , "lung carcinoma" , "lung tumor" , "risk" , "malignancy" , "carcinogenesis" , "prediction" , "assessment" , "model" , "tool" , "score" , "paradigm" , and "algorithm" were used as search keywords. Original articles were systematically searched from Chinese databases (CNKI, and Wanfang) and English databases (PubMed, Embase, Cochrane, and Web of Science) published prior to December 2018. The language of studies was restricted to Chinese and English. The inclusion criteria were human oriented studies with complete information for model development, validation and evaluation. The exclusion criteria were informal publications such as conference abstracts, Chinese dissertation papers, and research materials such as reviews, letters, and news reports. A total of 33 papers involving 27 models were included. The population characteristics of all included studies, study design, predicting factors and the performance of models were analyzed and compared.Results:Among 27 models, the number of American-based, European-based and Asian-based model studies was 12, 6 and 9, respectively. In addition, there were 6 Chinese-based model studies. According to the factors fitted into the models, these studies could be divided into traditional epidemiological models (11 studies), clinical index models (6 studies), and genetic index models (10 studies). 15 models were not validated after construction or were cross-validated only in the internal population, and the extrapolation effect of models was not effectively evaluated; 8 models were validated in single external population; only 4 models were verified in multiple external populations (3-7); the area under the curve (AUC) of models ranged from 0.57 to 0.90.Conclusion:Research on risk prediction models for lung cancer is in development stage. In addition to the lack of external validation of existing models, the exploration of potential clinical indicators was also limited.

Objective:To develop a lung cancer risk prediction model for female non-smokers.Methods:Based on the Kailuan prospective dynamic cohort (2006.05-2015.12), a nested case-control study was conducted. Participants diagnosed with primary pathologically confirmed lung cancer during follow-up were identified as the case group, and others were identified as the control group. A total of 24 701 subjects were included in the study, including 86 lung cancer cases and 24 615 control population, respectively. Questionnaires, physical examinations, and laboratory tests were conducted to collect relevant information. Multivariable-adjusted logistic regressions were conducted to develop a lung cancer risk prediction model. Area Under the Curve (AUC) and Hosmer-Lemeshow tests were used to evaluate discrimination and calibration, respectively. Ten-fold cross-validation was used for internal validation.Results:Two sets of models were developed: the simple model (including age and monthly income) and the metabolic index model [including age, monthly income, fasting blood glucose (FBG), total cholesterol (TC) and high-density lipoprotein cholesterol (HDL-C)].The AUC (95%CI) [0.745 (0.719-0.771)] of the metabolic index model was higher than that of the simple prediction model [0.688 (0.660-0.716)] ( P=0.004). Both the simple model ( PHL=0.287) and the metabolic index model ( PHL=0.134) were well-calibrated. The results of ten-fold cross-validation indicated sufficient stability, with an average AUC of 0.699 and a standard error (SD) of 0.010. Conclusion:By incorporating metabolic markers, accurate and reliable lung cancer risk prediction model for female non smokers could be developed.

Objective:To systematically understand the global research progress in the construction and validation of lung cancer risk prediction models.Methods:"lung neoplasms" , "lung cancer" , "lung carcinoma" , "lung tumor" , "risk" , "malignancy" , "carcinogenesis" , "prediction" , "assessment" , "model" , "tool" , "score" , "paradigm" , and "algorithm" were used as search keywords. Original articles were systematically searched from Chinese databases (CNKI, and Wanfang) and English databases (PubMed, Embase, Cochrane, and Web of Science) published prior to December 2018. The language of studies was restricted to Chinese and English. The inclusion criteria were human oriented studies with complete information for model development, validation and evaluation. The exclusion criteria were informal publications such as conference abstracts, Chinese dissertation papers, and research materials such as reviews, letters, and news reports. A total of 33 papers involving 27 models were included. The population characteristics of all included studies, study design, predicting factors and the performance of models were analyzed and compared.Results:Among 27 models, the number of American-based, European-based and Asian-based model studies was 12, 6 and 9, respectively. In addition, there were 6 Chinese-based model studies. According to the factors fitted into the models, these studies could be divided into traditional epidemiological models (11 studies), clinical index models (6 studies), and genetic index models (10 studies). 15 models were not validated after construction or were cross-validated only in the internal population, and the extrapolation effect of models was not effectively evaluated; 8 models were validated in single external population; only 4 models were verified in multiple external populations (3-7); the area under the curve (AUC) of models ranged from 0.57 to 0.90.Conclusion:Research on risk prediction models for lung cancer is in development stage. In addition to the lack of external validation of existing models, the exploration of potential clinical indicators was also limited.

Objective:To develop a lung cancer risk prediction model for female non-smokers.Methods:Based on the Kailuan prospective dynamic cohort (2006.05-2015.12), a nested case-control study was conducted. Participants diagnosed with primary pathologically confirmed lung cancer during follow-up were identified as the case group, and others were identified as the control group. A total of 24 701 subjects were included in the study, including 86 lung cancer cases and 24 615 control population, respectively. Questionnaires, physical examinations, and laboratory tests were conducted to collect relevant information. Multivariable-adjusted logistic regressions were conducted to develop a lung cancer risk prediction model. Area Under the Curve (AUC) and Hosmer-Lemeshow tests were used to evaluate discrimination and calibration, respectively. Ten-fold cross-validation was used for internal validation.Results:Two sets of models were developed: the simple model (including age and monthly income) and the metabolic index model [including age, monthly income, fasting blood glucose (FBG), total cholesterol (TC) and high-density lipoprotein cholesterol (HDL-C)].The AUC (95%CI) [0.745 (0.719-0.771)] of the metabolic index model was higher than that of the simple prediction model [0.688 (0.660-0.716)] ( P=0.004). Both the simple model ( PHL=0.287) and the metabolic index model ( PHL=0.134) were well-calibrated. The results of ten-fold cross-validation indicated sufficient stability, with an average AUC of 0.699 and a standard error (SD) of 0.010. Conclusion:By incorporating metabolic markers, accurate and reliable lung cancer risk prediction model for female non smokers could be developed.